Abstract Introduction The Alzheimer's Disease Neuroimaging Initiative (ADNI) has continued development and standardization of methodologies for biomarkers and has provided an …
Biomarkers in whichever modality are tremendously important in diagnosing of disease, tracking disease progression and clinical trials. This applies in particular for disorders with a …
J Turchi, C Chang, QY Frank, BE Russ, KY David… - Neuron, 2018 - cell.com
Patterns of spontaneous brain activity, typically measured in humans at rest with fMRI, are used routinely to assess the brain's functional organization. The mechanisms that generate …
Early identification of dementia at the stage of mild cognitive impairment (MCI) is crucial for timely diagnosis and intervention of Alzheimer's disease (AD). Although several pioneering …
Abstract Introduction The Alzheimer's Disease Neuroimaging Initiative (ADNI) separates “early” and “late” mild cognitive impairment (MCI) based on a single memory test. We …
Aim. Alzheimer's disease (AD) is a chronic neurodegenerative disease. Recently, computer scientists have developed various methods for early detection based on computer vision …
T Jitsuishi, A Yamaguchi - Scientific Reports, 2022 - nature.com
The intervention at the stage of mild cognitive impairment (MCI) is promising for preventing Alzheimer's disease (AD). This study aims to search for the optimal machine learning (ML) …
S Wang, Y Zhang, G Liu, P Phillips… - Journal of Alzheimer's …, 2016 - content.iospress.com
Background: Within the past decade, computer scientists have developed many methods using computer vision and machine learning techniques to detect Alzheimer's disease (AD) …
S Cai, T Chong, Y Peng, W Shen, J Li… - Brain imaging and …, 2017 - Springer
Amnestic mild cognitive impairment MCI (aMCI) has a high progression to Alzheimer's disease (AD). Recently, resting-state functional MRI (RS-fMRI) has been increasingly …